Filing Signals

Source: SEC EDGAR Compiled 2026-09-14 08:28 UTC All 21 checks passing

← All events

ACADIA PHARMACEUTICALS INC

CIK 1070494 ACAD·Pharmaceutical Preparations · All EDGAR filings ↗

Accounting standard newly cited Filing comparison

ACADIA PHARMACEUTICALS INC cited accounting standard ASU 2023-09 for the first time in this filing series

The Company adopted ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures on a prospective basis.
Evidence
Adopted
2023-09
Contexts
The Company adopted ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures on a prospective basis.
New standards
2023-09
Prior filed
2025-02-27
Prior form
10-K
Restates existing policy
No
Source
accounting standards update (ASU) reference comparison
Why
An accounting standard (ASU) appears in this filing that did not appear in the previous comparable one, in a sentence describing it as adopted. That is a change in what the company discloses, which is not always a change of policy in the current period: the filing may state an adoption date years earlier.